ロード中...

Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder

To date, there are no biomarkers for major depressive disorder (MDD) treatment response in clinical use. Such biomarkers could allow for individualized treatment selection, reducing time spent on ineffective treatments and the burden of MDD. In search of such a biomarker, multisite pretreatment and...

詳細記述

保存先:
書誌詳細
出版年:Neuropsychopharmacology
主要な著者: Bartlett, Elizabeth A., DeLorenzo, Christine, Sharma, Priya, Yang, Jie, Zhang, Mengru, Petkova, Eva, Weissman, Myrna, McGrath, Patrick J., Fava, Maurizio, Ogden, R. Todd, Kurian, Benji T., Malchow, Ashley, Cooper, Crystal M., Trombello, Joseph M., McInnis, Melvin, Adams, Phillip, Oquendo, Maria A., Pizzagalli, Diego A., Trivedi, Madhukar, Parsey, Ramin V.
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135779/
https://ncbi.nlm.nih.gov/pubmed/29955151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-018-0122-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!